Your browser doesn't support javascript.
loading
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.
Matulonis, U A; Penson, R T; Domchek, S M; Kaufman, B; Shapira-Frommer, R; Audeh, M W; Kaye, S; Molife, L R; Gelmon, K A; Robertson, J D; Mann, H; Ho, T W; Coleman, R L.
Afiliación
  • Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. Electronic address: ursula_matulonis@dfci.harvard.edu.
  • Penson RT; Department of Hematology/Oncology, Massachusetts General Hospital, Boston.
  • Domchek SM; Department of Medicine, Basser Research Center and Abramson Cancer Center, Philadelphia, USA.
  • Kaufman B; Division of Oncology, Sheba Medical Center, Tel HaShomer, Israel.
  • Shapira-Frommer R; Division of Oncology, Sheba Medical Center, Tel HaShomer, Israel.
  • Audeh MW; Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Kaye S; Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.
  • Molife LR; Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.
  • Gelmon KA; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada.
  • Robertson JD; Global Medicines Development, AstraZeneca, Macclesfield, UK.
  • Mann H; Global Medicines Development, AstraZeneca, Macclesfield, UK.
  • Ho TW; Global Medicines Development, AstraZeneca, Wilmington.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.
Ann Oncol ; 27(6): 1013-1019, 2016 06.
Article en En | MEDLINE | ID: mdl-26961146

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article